Adiponectin is positively associated with insulin resistance in subjects with type 2 diabetic nephropathy and effects of angiotensin II type 1 receptor blocker losartan.
about
Serum Adiponectin and Glomerular Filtration Rate in Patients with Type 2 Diabetes.Exploring metabolic dysfunction in chronic kidney disease.Hypoadiponectinemia in patients with paroxysmal atrial fibrillationEffect of various treatments on leptin, adiponectin, ghrelin and neuropeptide Y in patients with type 2 diabetes mellitus.The effect of amlodipine besylate, losartan potassium, olmesartan medoxomil, and other antihypertensives on central aortic blood pressure and biomarkers of vascular function.Adiponectin in renal disease--a review of the evidence as a risk factor for cardiovascular and all-cause mortality.Association of adiponectin polymorphisms with the risk of diabetic nephropathy in type 2 diabetes: a meta-analysis.Adiponectin diminishes platelet aggregation and sCD40L release. Potential role in the metabolic syndrome.Association of ADIPOQ genetic variants and plasma adiponectin isoforms with the risk of incident renal events in type 2 diabetes.Effects of losartan/hydrochlorothiazide treatment, after change from ARB at usual dosage, on blood pressure and various metabolic parameters including high-molecular weight adiponectin in Japanese male hypertensive subjects.Effect of renin-angiotensin-aldosterone system blockade in adults with diabetes mellitus and advanced chronic kidney disease not on dialysis: a systematic review and meta-analysis.Different actions of losartan and ramipril on adipose tissue activity and vascular remodeling biomarkers in hypertensive patients.Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR <45 mL/min).
P2860
Q35806232-263C38AA-E3D5-4407-8A26-05729CB2F84CQ36123347-A10ED8B8-1E3E-4AB0-92AF-CCACD64E65BCQ36385440-69F1BE68-6107-453E-9EB7-A56CE87DBA2AQ37831911-AE868799-36F4-47A7-87DE-BB739096344FQ37926767-BC5B0D25-90A9-4A7C-AE1D-3E0C1903EB06Q38065246-78AEE933-B907-4461-9E5E-D0ADE090754AQ38211620-8131FA3F-2543-45F1-AD27-C30553928DA9Q43144687-3F25186B-26DE-4BB9-84A7-20611A02D943Q43190717-964CF21C-2B90-4845-8584-5165A4471711Q47401707-CF8B6F69-02FF-4D2C-B0A6-23CE46B3A215Q49048863-1EE1B44F-83E3-4177-8BB5-E779A3F4A15EQ51386085-7912963E-FA89-47A5-A6E6-7D82F04AA6F1Q53519441-8554D103-8293-43F7-B622-0E0FA395B5D5
P2860
Adiponectin is positively associated with insulin resistance in subjects with type 2 diabetic nephropathy and effects of angiotensin II type 1 receptor blocker losartan.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Adiponectin is positively asso ...... e 1 receptor blocker losartan.
@en
type
label
Adiponectin is positively asso ...... e 1 receptor blocker losartan.
@en
prefLabel
Adiponectin is positively asso ...... e 1 receptor blocker losartan.
@en
P2093
P2860
P356
P1476
Adiponectin is positively asso ...... e 1 receptor blocker losartan.
@en
P2093
P2860
P304
P356
10.1093/NDT/GFN770
P407
P577
2009-01-22T00:00:00Z